← Leaderboards
Amit Kapoor
Research Inst Nationwide Children'S Hosp
$13,758,670
Attributed
$14,747,457
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,747,457 · 14
By mechanism
R01$11,435,071 · 6
R21$3,312,386 · 8
Top collaborators
- Zongdi Feng5 shared
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirusInfectionVirus DiseasesPreventAnimal ModelChronicReportingInsightSerumProteinsHepatitis C VirusRattusRodentGenomeVariantMolecularCellsAnimalsInnovationPathogenesisImmuneSamplingTransmission Process
Grant awards (38)
Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis$780,961
R01 · FY2025 · AI · contact PI
Viral Determinants of Chronic Hepacivirus Infection$665,540
R01 · FY2025 · AI · contact PI
Mechanism for hepatitis E virus exit from polarized hepatocytes$518,025
R01 · FY2025 · AI
Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis$794,961
R01 · FY2024 · AI · contact PI
Viral Determinants of Chronic Hepacivirus Infection$665,540
R01 · FY2024 · AI · contact PI
Immune correlates of protection against hepacivirus persistence.$614,828
R01 · FY2024 · AI · contact PI
Mechanism for hepatitis E virus exit from polarized hepatocytes$518,025
R01 · FY2024 · AI
A sequence-independent approach for attenuating hepaciviruses$234,000
R21 · FY2024 · AI · contact PI
Immune correlates of protection against hepacivirus persistence.$614,828
R01 · FY2023 · AI · contact PI
Mechanism for hepatitis E virus exit from polarized hepatocytes$518,025
R01 · FY2023 · AI
A sequence-independent approach for attenuating hepaciviruses$195,000
R21 · FY2023 · AI · contact PI
Immune correlates of protection against hepacivirus persistence.$614,828
R01 · FY2022 · AI · contact PI
Host response and liver disease in a hepatitis C-like virus rat model$478,475
R01 · FY2022 · AI · contact PI
Infection and prevalence of a new segmented flavivirus in the United States$193,513
R21 · FY2022 · AI · contact PI
Role of a secreted form of ORF2 protein in hepatitis E virus infection$192,500
R21 · FY2022 · AI
Immune correlates of protection against hepacivirus persistence.$642,072
R01 · FY2021 · AI · contact PI
Host response and liver disease in a hepatitis C-like virus rat model$486,029
R01 · FY2021 · AI · contact PI
Infection and prevalence of a new segmented flavivirus in the United States$246,525
R21 · FY2021 · AI · contact PI
Role of a secreted form of ORF2 protein in hepatitis E virus infection$231,000
R21 · FY2021 · AI
Host response and liver disease in a hepatitis C-like virus rat model$496,663
R01 · FY2020 · AI · contact PI
Murine model for Torque teno viruses - Resubmission - 1$190,000
R21 · FY2020 · AI · contact PI
Host response and liver disease in a hepatitis C-like virus rat model$507,238
R01 · FY2019 · AI · contact PI
Murine model for Torque teno viruses - Resubmission - 1$228,000
R21 · FY2019 · AI · contact PI
Host response and liver disease in a hepatitis C-like virus rat model$543,426
R01 · FY2018 · AI · contact PI
Novel viruses and viral dynamics in multiple transfusion recipients$370,989
R01 · FY2018 · HL · contact PI
Origin and evolution of virome in development of post-transfusion hepatitis$114,000
R21 · FY2018 · HL · contact PI
Novel viruses and viral dynamics in multiple transfusion recipients$381,574
R01 · FY2017 · HL · contact PI
Origin and evolution of virome in development of post-transfusion hepatitis$113,625
R21 · FY2017 · HL · contact PI
Novel viruses and viral dynamics in multiple transfusion recipients$404,339
R01 · FY2016 · HL · contact PI
Novel viruses and viral dynamics in multiple transfusion recipients$398,816
R01 · FY2015 · HL · contact PI
Study of rodent HCV-GBV like viruses$190,785
R21 · FY2015 · AI · contact PI
Study of rodent HCV-GBV like viruses$58,014
R21 · FY2015 · AI · contact PI
Novel viruses and viral dynamics in multiple transfusion recipients$419,889
R01 · FY2014 · HL · contact PI
Study of rodent HCV-GBV like viruses$223,559
R21 · FY2014 · AI · contact PI
Study of a novel picornavirus genus associated with Acute Flaccid Paralysis$190,812
R21 · FY2012 · AI · contact PI
Study of a novel picornavirus genus associated with Acute Flaccid Paralysis$256,885
R21 · FY2011 · AI · contact PI
Molecular Characterization of Novel Astroviruses$198,293
R21 · FY2011 · AI · contact PI
Molecular Characterization of Novel Astroviruses$255,875
R21 · FY2010 · AI · contact PI